IRIS Accounts Production v24.3.0.553 SC759765 Board of Directors 1.8.23 31.7.24 31.7.24 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC7597652023-07-31SC7597652024-07-31SC7597652023-08-012024-07-31SC7597652023-02-21SC7597652023-02-222023-07-31SC7597652023-07-31SC759765ns15:Scotland2023-08-012024-07-31SC759765ns14:PoundSterling2023-08-012024-07-31SC759765ns10:Director12023-08-012024-07-31SC759765ns10:PrivateLimitedCompanyLtd2023-08-012024-07-31SC759765ns10:SmallEntities2023-08-012024-07-31SC759765ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-31SC759765ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-31SC759765ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-31SC759765ns10:FullAccounts2023-08-012024-07-31SC75976512023-08-012024-07-31SC759765ns10:OrdinaryShareClass12023-08-012024-07-31SC759765ns10:Director22023-08-012024-07-31SC759765ns10:Director32023-08-012024-07-31SC759765ns10:RegisteredOffice2023-08-012024-07-31SC759765ns5:CurrentFinancialInstruments2024-07-31SC759765ns5:CurrentFinancialInstruments2023-07-31SC759765ns5:Non-currentFinancialInstruments2024-07-31SC759765ns5:Non-currentFinancialInstruments2023-07-31SC759765ns5:ShareCapital2024-07-31SC759765ns5:ShareCapital2023-07-31SC759765ns5:SharePremium2024-07-31SC759765ns5:SharePremium2023-07-31SC759765ns5:RetainedEarningsAccumulatedLosses2024-07-31SC759765ns5:RetainedEarningsAccumulatedLosses2023-07-31SC759765ns5:NetGoodwill2023-08-012024-07-31SC759765ns5:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-31SC759765ns5:PlantMachinery2023-08-012024-07-31SC759765ns5:FurnitureFittings2023-08-012024-07-31SC759765ns5:NetGoodwill2023-07-31SC759765ns5:NetGoodwill2024-07-31SC759765ns5:NetGoodwill2023-07-31SC759765ns5:LandBuildings2023-07-31SC759765ns5:PlantMachinery2023-07-31SC759765ns5:FurnitureFittings2023-07-31SC759765ns5:LandBuildings2023-08-012024-07-31SC759765ns5:LandBuildings2024-07-31SC759765ns5:PlantMachinery2024-07-31SC759765ns5:FurnitureFittings2024-07-31SC759765ns5:LandBuildings2023-07-31SC759765ns5:PlantMachinery2023-07-31SC759765ns5:FurnitureFittings2023-07-31SC759765ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-07-31SC759765ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-07-31SC759765ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-07-31SC759765ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-07-31SC759765ns10:OrdinaryShareClass12024-07-31SC759765ns5:RetainedEarningsAccumulatedLosses2023-07-31SC759765ns5:SharePremium2023-07-31SC759765ns5:RetainedEarningsAccumulatedLosses2023-08-012024-07-31
REGISTERED NUMBER: SC759765 (Scotland)















Unaudited Financial Statements For The Year Ended 31 July 2024

for

STRATHCLYDE HEALTHCARE LTD

STRATHCLYDE HEALTHCARE LTD (Registered number: SC759765)






Contents of the Financial Statements
For The Year Ended 31 July 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


STRATHCLYDE HEALTHCARE LTD

Company Information
For The Year Ended 31 July 2024







DIRECTORS: J R Higgins
R J Haldane
C D Morrison





REGISTERED OFFICE: Kennoway Pharmacy
Bishops Court
Kennoway
Leven
KY11 8SX





REGISTERED NUMBER: SC759765 (Scotland)





ACCOUNTANTS: Ahmad & Nabi Mcmullan
95-107 Lancefield Street
Glasgow
Lanarkshire
G3 8HZ

STRATHCLYDE HEALTHCARE LTD (Registered number: SC759765)

Balance Sheet
31 July 2024

31.7.24 31.7.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 851,098 851,098
Tangible assets 5 94,658 97,322
945,756 948,420

CURRENT ASSETS
Stocks 68,933 34,000
Debtors 6 100,622 19,955
Cash at bank and in hand 142,847 23,219
312,402 77,174
CREDITORS
Amounts falling due within one year 7 380,834 283,124
NET CURRENT LIABILITIES (68,432 ) (205,950 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

877,324

742,470

CREDITORS
Amounts falling due after more than one
year

8

726,559

772,000
NET ASSETS/(LIABILITIES) 150,765 (29,530 )

CAPITAL AND RESERVES
Called up share capital 9 1,000 1,000
Share premium 10 85,000 85,000
Retained earnings 10 64,765 (115,530 )
SHAREHOLDERS' FUNDS 150,765 (29,530 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

STRATHCLYDE HEALTHCARE LTD (Registered number: SC759765)

Balance Sheet - continued
31 July 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 October 2024 and were signed on its behalf by:





J R Higgins - Director


STRATHCLYDE HEALTHCARE LTD (Registered number: SC759765)

Notes to the Financial Statements
For The Year Ended 31 July 2024

1. STATUTORY INFORMATION

STRATHCLYDE HEALTHCARE LTD is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2023, is being amortised evenly over its estimated useful life of nil years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% on reducing balance
Fixtures and fittings - 20% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

STRATHCLYDE HEALTHCARE LTD (Registered number: SC759765)

Notes to the Financial Statements - continued
For The Year Ended 31 July 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 13 (2023 - 5 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 August 2023
and 31 July 2024 851,098
NET BOOK VALUE
At 31 July 2024 851,098
At 31 July 2023 851,098

5. TANGIBLE FIXED ASSETS
Fixtures
Freehold Plant and and
property machinery fittings Totals
£    £    £    £   
COST
At 1 August 2023
and 31 July 2024 84,000 13,903 2,750 100,653
DEPRECIATION
At 1 August 2023 - 2,781 550 3,331
Charge for year - 2,224 440 2,664
At 31 July 2024 - 5,005 990 5,995
NET BOOK VALUE
At 31 July 2024 84,000 8,898 1,760 94,658
At 31 July 2023 84,000 11,122 2,200 97,322

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Trade debtors 82,252 3,161
VAT 18,370 16,794
100,622 19,955

STRATHCLYDE HEALTHCARE LTD (Registered number: SC759765)

Notes to the Financial Statements - continued
For The Year Ended 31 July 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Bank loans and overdrafts 26,000 -
Trade creditors 87,107 24,218
Tax 19,437 -
Social security and other taxes 1,187 -
Pension due 333 -
Other creditors 226,500 256,500
Directors' current accounts 17,194 1,566
Accrued expenses 3,076 840
380,834 283,124

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.7.24 31.7.23
£    £   
Bank loans 726,559 772,000

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.7.24 31.7.23
value: £    £   
1,000 Ordinary £1.00 1,000 1,000

10. RESERVES
Retained Share
earnings premium Totals
£    £    £   

At 1 August 2023 (115,530 ) 85,000 (30,530 )
Profit for the year 180,295 180,295
At 31 July 2024 64,765 85,000 149,765